RBC Capital Reaffirms Their Buy Rating on Elevance Health (ELV)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Elevance Health, and HCA Healthcare. According to TipRanks, Hendrix has an average return of 1.6% and a 46.08% success rate on recommended stocks.
In addition to RBC Capital, Elevance Health also received a Buy from Bernstein's Lance Wilkes in a report issued yesterday. However, on the same day, Argus Research downgraded Elevance Health (NYSE: ELV) to a Hold.
Based on Elevance Health's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $60.04 billion and a net profit of $2.28 billion. In comparison, last year the company earned a revenue of $43.65 billion and had a net profit of $2.3 billion
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is neutral on the stock. Most recently, in April 2025, Mark Kaye, the EVP & CFO of ELV sold 4,588.00 shares for a total of $1,949,074.16.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
26 minutes ago
- Business Insider
Is AMD Stock a Buy Ahead of Q2 Earnings? Here's Wall Street's Take
All eyes are on Advanced Micro Devices' (AMD) second-quarter earnings that are scheduled to be announced on August 5. AMD stock has rallied about 38% year-to-date, driven by strong Q1 results, encouraging updates at the Advancing AI event, lifting of chip export restrictions, and revived hopes for the company's prospects in the artificial intelligence (AI) chips market. Ahead of the results, Wall Street is cautiously optimistic on AMD stock. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Expectations from AMD's Q2 Earnings AMD delivered impressive first-quarter results, with its data center segment's revenue rising 57%. The company's overall revenue growth has been accelerating in recent quarters. Wall Street expects AMD to report earnings per share (EPS) of $0.48 for Q2 2025, reflecting a 30% year-over-year decline. Meanwhile, revenue is estimated to grow by 27% to $7.41 billion. Looking ahead, Advanced Micro Devices' latest Instinct MI350X and MI355X graphics processing units (GPUs), which compete with Nvidia's (NVDA) Blackwell platform, are expected to boost its AI revenue. Moreover, the upcoming MI400X AI accelerator is expected to drive AMD's top-line higher. Analysts' Views Ahead of AMD's Q2 Results Heading into the Q2 results, Erste Group analyst Stephan Lingnau upgraded AMD stock from Hold to Buy, noting that the company sees further growth in 2025 based on the growing demand for high-performance CPUs and GPUs in data center environments. The analyst expects AMD's operating margin to increase in the medium term and profit growth to accelerate significantly next year. Lingnau expects AMD stock to continue to rise, given the company's 'good growth prospects.' Meanwhile, Citi analyst Christopher Danely increased his price target for AMD stock to $165 from $145, while maintaining a Hold rating. The 5-star analyst expects AMD stock to move higher ahead of the Q2 earnings report, driven by improving sentiment and the company's strong positioning in AI-related growth. That said, Danely is concerned that buy-side expectations for AMD may be too high. Is AMD Stock a Good Buy? Overall, Wall Street has a Moderate Buy consensus rating on Advanced Micro Devices stock based on 26 Buys and 10 Holds. The average AMD stock price target of $145.90 indicates a possible downside of 12.4% from current levels.
Yahoo
29 minutes ago
- Yahoo
Chubb Limited (CB): An Oversold Insurance Giant with a Growing Dividend
Chubb Limited (NYSE:CB) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. A close-up of an insurance agent's hand pointing to a marine insurance policy, highlighting the company's expertise in marine coverage. Chubb Limited (NYSE:CB) ranks among the largest publicly traded property and casualty insurers in the world. In recent years, the company has worked to grow its presence outside of North America, with particular focus on markets in Asia, Latin America, and Europe. Its strategy centers on disciplined underwriting, meaning it takes a careful approach to selecting which risks to insure and how to price them, while also aiming to manage risk across multiple product lines and regions. In the second quarter of 2025, Chubb Limited (NYSE:CB) reported P&C net premiums written of $12.39 billion, which showed a 5.2% growth from the same period last year. Net income rose to $2.97 billion, marking an increase of 33.1%, while core operating income reached a record high of $2.48 billion, reflecting a 12.9% gain. Property and casualty underwriting income reached a record $1.63 billion, representing a 15.0% increase, while the combined ratio stood at 85.6%. Chubb Limited (NYSE:CB)'s cash position also remained stable during the quarter. The company's operating cash flow came in at $3.55 billion and ended the quarter with cash and cash equivalents of $2.4 billion. During the quarter, the company also returned $388 million to shareholders through dividends. In addition, it holds a 32-year streak of consistent dividend growth. The company offers a quarterly dividend of $0.97 per share and has a dividend yield of 1.44%, as of July 25. While we acknowledge the potential of CB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
Palantir (PLTR) Stock Rallies After Analyst Cites Unique ‘Growth and Margin' Model
Shares of Palantir Technologies (PLTR) rallied to a new 52-week high of $160.06 this morning, after Piper Sandler analyst Brent Bracelin cited its unique growth and margin model. Bracelin initiated coverage of PLTR stock with a 'Buy' rating and a new Street-High price target of $170, which implies 9.8% upside potential from current levels. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The analyst foresees significant growth potential for the big data analytics company in its two prime markets: government contracts and U.S. commercial sectors. Palantir's shares have skyrocketed over 104% so far in 2025, backed by rapidly growing demand for artificial intelligence (AI). While other analysts remain skeptical of PLTR's sky-high valuation, Bracelin appears even more optimistic about Palantir's future prospects. Palantir Has a Unique Growth and Margin Model The analyst noted that Palantir has a 'one-of-a-kind' growth and margin model, with potential to reach $24 billion in annual run-rate by 2032. Bracelin added that both of Palantir's end markets, government and U.S. commercial customers, have a total addressable market (TAM) of around one trillion dollars each. He also recommends that investors watch the stock and buy shares on dips, since he views the company as one of the biggest winners of the AI revolution. According to Bracelin, the company currently has a roughly $4 billion revenue run-rate and a free cash flow margin exceeding 40%. He forecasts that revenue from Palantir's U.S. government business could exceed $10 billion by 2030, with its U.S. commercial business reaching $5 billion in revenue by the decade's end. Palantir's U.S. Business Is Expected to Explode As shown by Palantir's KPI data from Main Street Data, the company's government and commercial segments are experiencing robust growth, with the government segment on a significant upward trajectory. During Q1FY25, Palantir's U.S. government revenue grew 45% year-over-year, while U.S. commercial revenue grew 71% compared to the prior year period. The company's strategic focus on AI-driven solutions is driving substantial gains, particularly in the U.S. market, and this momentum is expected to continue into the future. Is PLTR Stock a Buy, Hold, or Sell? Currently, analysts remain cautious about Palantir's long-term outlook. On TipRanks, PLTR stock has a Hold consensus rating based on four Buys, 10 Holds, and three Sell ratings. Also, the average Palantir price target of $109.50 implies 29.3% downside potential from current levels.
